| COPD | Chronic Obstructive Pulmonary Disease |
| A1ATD | Alpha-1 Antitrypsin Deficiency (alternative notation) |
| FEV1 | Forced Expiratory Volume in 1 Second |
| FVC | Forced Vital Capacity |
| FEV1/FVC | Ratio of Forced Expiratory Volume in 1 Second to Forced Vital Capacity |
| DLCO | Diffusing Capacity for Carbon Monoxide |
| NLR | Neutrophil-to-Lymphocyte Ratio |
| FeNO | Fractional Exhaled Nitric Oxide |
| TNF-α | Tumor Necrosis Factor-alpha |
| IL-8 | Interleukin-8 |
| MMPs | Matrix Metalloproteinases |
| mMRC | Modified Medical Research Council Dyspnea Scale |
| CAT | COPD Assessment Test |
| GOLD | Global Initiative for Chronic Obstructive Lung Disease |
| KOCOSS | Korea COPD Subgroup Study |
| VGDF | Vapors, Gases, Dusts, and Fumes |
| PM2.5 | Particulate Matter ≤ 2.5 μm |
| PM10 | Particulate Matter ≤ 10 μm |
| NOx | Nitrogen Oxides |
| NO2 | Nitrogen Dioxide |
| CO | Carbon Monoxide |
| HIV | Human Immunodeficiency Virus |
| TB | Tuberculosis |
| CD8+ T cells | Cluster of Differentiation 8 Positive T Lymphocytes |
| OR | Odds Ratio |
| CI | Confidence Interval |
| BMI | Body Mass Index |
| CT | Computed Tomography |
| QoL | Quality of Life |